PMDA drug package insert
ユーエフティ配合カプセルT100
PMDA Prescription drug · 大鵬薬品工業株式会社 · package insert Jan 29, 2025
Key facts
| Brand names | ユーエフティ配合カプセルT100, ユーエフティE配合顆粒T100, ユーエフティE配合顆粒T150, ユーエフティE配合顆粒T200 |
|---|---|
| Nonproprietary names | テガフール・ウラシル |
| Companies | 製造販売元／大鵬薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 代謝拮抗剤 |
| Therapeutic category codes | 874229 |
| YJ codes | 4229100M2035, 4229100D3023, 4229100D4020, 4229100D5026 |
| Approval numbers | 22100AMX00783000, 22100AMX00782000, 22100AMX00781000, 22100AMX00803000 |
| Package insert edition | 第2版 |
| Package insert date | Jan 29, 2025 |
| PMDA document key | 400107_4229100D3023_1 |
| PMDA company code | 400107 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: